Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Jarrow Formulas, Inc. Unveils Pressure Optimizer(TM), With AmealPeptide(TM), a Patented Extract of Hydrolyzed Casein
Company announces the introduction of Pressure Optimizer(TM), with primary constituent is AmealPeptide(TM), a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
- Jarrow Formulas, Inc. Unveils Pressure Optimizer(TM), With AmealPeptide(TM), a Patented Extract of Hydrolyzed Casein
Company announces the introduction of Pressure Optimizer(TM), with primary constituent is AmealPeptide(TM), a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- Celanese Has Sold Its omega-3 DHA Business to Lonza
Company has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- EFSA Launches Public Consultation on its General Approach to Establishing Dietary Reference Values
EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) has today launched a public consultation on its draft general principles for establishing Dietary Reference Values. EFSA is consulting on its draft opinion in order to ensure that the Panel takes into account all available data and benefits from the experience of public health bodies in the European Union (EU) and worldwide in setting Dietary Reference Values for the different nutrients.
- DSM Nutritional Products Increases Prices for Beta-Carotene and Lycopene
DSM Nutritional Products announces a global price increase for Beta-Carotene and Lycopene. Further to recent announcements of price increases for fat soluble vitamins, the Carotenoids, Beta-Carotene and Lycopene, marketed in the human nutrition industries, will now increase in price by a minimum of 10% for all newly contracted business. These price increases are driven by sharp increases in raw material prices, energy and transportation costs.
- DSM Nutritional Products Increases Prices for Beta-Carotene and Lycopene
DSM Nutritional Products announces a global price increase for Beta-Carotene and Lycopene. Further to recent announcements of price increases for fat soluble vitamins, the Carotenoids, Beta-Carotene and Lycopene, marketed in the human nutrition industries, will now increase in price by a minimum of 10% for all newly contracted business. These price increases are driven by sharp increases in raw material prices, energy and transportation costs.
- DSM Nutritional Products Increases Prices for Beta-Carotene and Lycopene
DSM Nutritional Products announces a global price increase for Beta-Carotene and Lycopene. Further to recent announcements of price increases for fat soluble vitamins, the Carotenoids, Beta-Carotene and Lycopene, marketed in the human nutrition industries, will now increase in price by a minimum of 10% for all newly contracted business. These price increases are driven by sharp increases in raw material prices, energy and transportation costs.
- Optimum Nutrition’s Vassive-N.O.® Now Available in 70-Serving Economy Size
Optimum Nutrition’s Vassive-N.O.® premium supplement is now available in a new 70-serving economy size.
- Optimum Nutrition’s Vassive-N.O.® Now Available in 70-Serving Economy Size
Optimum Nutrition’s Vassive-N.O.® premium supplement is now available in a new 70-serving economy size.
- Optimum Nutrition’s Vassive-N.O.® Now Available in 70-Serving Economy Size
Optimum Nutrition’s Vassive-N.O.® premium supplement is now available in a new 70-serving economy size.
- Optimum Nutrition’s Vassive-N.O.® Now Available in 70-Serving Economy Size
Optimum Nutrition’s Vassive-N.O.® premium supplement is now available in a new 70-serving economy size.
- Optimum Nutrition’s Vassive-N.O.® Now Available in 70-Serving Economy Size
Optimum Nutrition’s Vassive-N.O.® premium supplement is now available in a new 70-serving economy size.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 )
BioGaia has announced their interim report for January 1, 2008 through June 30, 2008, reporting (previous year's results are in brackets)net sales amounted to SEK 72.4 million (51.2), an increase of 41% compared to the same period of last year. Gross profit reached SEK 47.8 million, an improvement of SEK 13.6 million over the same period of last year. Profit after tax was SEK 22.1 million (3.3), an increase of SEK 18.8 million compared to the same period of last year.
- JAMA’s Study on B Vitamins Lacks Essential Exclusion Criteria and Controls, Says Association
JAMA, the Journal of the American Medical Association, is releasing a report on a clinical trial that concluded that use of B vitamins was not effective for preventing death or cardiovascular events. The study will appear in the August 20 issue of the journal. In response to the findings, the Natural Products Association has issued a statement from Vice President of Scientific and Regulatory Affairs Daniel Fabricant, Ph.D., claiming the study lacks essential exclusion criteria and controls.
- JAMA’s Study on B Vitamins Lacks Essential Exclusion Criteria and Controls, Says Association
JAMA, the Journal of the American Medical Association, is releasing a report on a clinical trial that concluded that use of B vitamins was not effective for preventing death or cardiovascular events. The study will appear in the August 20 issue of the journal. In response to the findings, the Natural Products Association has issued a statement from Vice President of Scientific and Regulatory Affairs Daniel Fabricant, Ph.D., claiming the study lacks essential exclusion criteria and controls.
- NPI Daily - Top of The News for August 20, 2008 - JAMA's Study on B Vitamins Lacks Essential Exclusion Criteria and Controls, Says Association
BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 ); EFSA Launches Public Consultation on its Draft Scientific Opinion on Food-Based Dietary Guidelines; UNPA Members Honored With Nutrition Business Journal Business Achievement Awards; EFSA Launches Public Consultation on its General Approach to Establishing Dietary Reference Values; Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study; JAMA's Study on B Vitamins Lacks Essential Exclusion Criteria and Controls, Says Association; Study Suggests Organic Food Is Not More Nutritional; Applegate Farms Launches Probiotic Yoghurt Cheese; DSM Nutritional Products Increases Prices for Beta-Carotene and Lycopene
- NPI Daily - Top of The News for August 20, 2008 - JAMA's Study on B Vitamins Lacks Essential Exclusion Criteria and Controls, Says Association
BioGaia Releases Their AB Interim Report (1 January – 30 June 2008 ); EFSA Launches Public Consultation on its Draft Scientific Opinion on Food-Based Dietary Guidelines; UNPA Members Honored With Nutrition Business Journal Business Achievement Awards; EFSA Launches Public Consultation on its General Approach to Establishing Dietary Reference Values; Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study; JAMA's Study on B Vitamins Lacks Essential Exclusion Criteria and Controls, Says Association; Study Suggests Organic Food Is Not More Nutritional; Applegate Farms Launches Probiotic Yoghurt Cheese; DSM Nutritional Products Increases Prices for Beta-Carotene and Lycopene
- Visitors to Men's Sexual Health Supplement Site Decide if Products' New Ads Deserve a 'Thumbs Up'
Life Span labs is allowing visitors to their 112 Degrees product website whether or not they like their new advertising concepts.
- Visitors to Men's Sexual Health Supplement Site Decide if Products' New Ads Deserve a 'Thumbs Up'
Life Span labs is allowing visitors to their 112 Degrees product website whether or not they like their new advertising concepts.
- Mineral Resources International, Inc. Issues Cease and Desist Letter to Trace Minerals Research, L.C. Concerning Trademark Infringement and False Advertising
On July 25, 2008, Mineral Resources International, Inc. (MRI) issued a letter to Trace Minerals Research, L.C. (TMR) calling on TMR to cease and desist from trademark infringement and false advertising concerning MRI’s elete Electrolyte Add-In™ (elete) brand name. MRI is calling for remedial action from TMR in the form of corrective advertising and, if appropriate, a product recall.
- Mineral Resources International, Inc. Issues Cease and Desist Letter to Trace Minerals Research, L.C. Concerning Trademark Infringement and False Advertising
On July 25, 2008, Mineral Resources International, Inc. (MRI) issued a letter to Trace Minerals Research, L.C. (TMR) calling on TMR to cease and desist from trademark infringement and false advertising concerning MRI’s elete Electrolyte Add-In™ (elete) brand name. MRI is calling for remedial action from TMR in the form of corrective advertising and, if appropriate, a product recall.
- Mineral Resources International, Inc. Issues Cease and Desist Letter to Trace Minerals Research, L.C. Concerning Trademark Infringement and False Advertising
On July 25, 2008, Mineral Resources International, Inc. (MRI) issued a letter to Trace Minerals Research, L.C. (TMR) calling on TMR to cease and desist from trademark infringement and false advertising concerning MRI’s elete Electrolyte Add-In™ (elete) brand name. MRI is calling for remedial action from TMR in the form of corrective advertising and, if appropriate, a product recall.
- Mineral Resources International, Inc. Issues Cease and Desist Letter to Trace Minerals Research, L.C. Concerning Trademark Infringement and False Advertising
On July 25, 2008, Mineral Resources International, Inc. (MRI) issued a letter to Trace Minerals Research, L.C. (TMR) calling on TMR to cease and desist from trademark infringement and false advertising concerning MRI’s elete Electrolyte Add-In™ (elete) brand name. MRI is calling for remedial action from TMR in the form of corrective advertising and, if appropriate, a product recall.
- Mineral Resources International, Inc. Issues Cease and Desist Letter to Trace Minerals Research, L.C. Concerning Trademark Infringement and False Advertising
On July 25, 2008, Mineral Resources International, Inc. (MRI) issued a letter to Trace Minerals Research, L.C. (TMR) calling on TMR to cease and desist from trademark infringement and false advertising concerning MRI’s elete Electrolyte Add-In™ (elete) brand name. MRI is calling for remedial action from TMR in the form of corrective advertising and, if appropriate, a product recall.
- Four "Hi-Tech Pharmaceuticals" Case Defendants Plead Guilty to Importing and Distributing "Knock-Off" Prescription Drugs
Four men based in Georgia, USA, have plead guilty to conspiring to import and distribute adulterated, mislabeled and unapproved new drugs, and to commit mail and wire fraud.
- Four "Hi-Tech Pharmaceuticals" Case Defendants Plead Guilty to Importing and Distributing "Knock-Off" Prescription Drugs
Four men based in Georgia, USA, have plead guilty to conspiring to import and distribute adulterated, mislabeled and unapproved new drugs, and to commit mail and wire fraud.
- Dr. Linong Ji Joins Herbalife's Nutrition Advisory Board
Herbalife Ltd., has announced that Dr. Linong Ji has joined the company's Nutrition Advisory Board. The nutrition advisory board is comprised of leading experts around the world in the fields of nutrition and health who educate and train Herbalife independent distributors and, in China, sales employees on the principles of nutrition, physical activity and healthy lifestyle.
- Dr. Linong Ji Joins Herbalife's Nutrition Advisory Board
Herbalife Ltd., has announced that Dr. Linong Ji has joined the company's Nutrition Advisory Board. The nutrition advisory board is comprised of leading experts around the world in the fields of nutrition and health who educate and train Herbalife independent distributors and, in China, sales employees on the principles of nutrition, physical activity and healthy lifestyle.
- Dr. Linong Ji Joins Herbalife's Nutrition Advisory Board
Herbalife Ltd., has announced that Dr. Linong Ji has joined the company's Nutrition Advisory Board. The nutrition advisory board is comprised of leading experts around the world in the fields of nutrition and health who educate and train Herbalife independent distributors and, in China, sales employees on the principles of nutrition, physical activity and healthy lifestyle.
- Dr. Linong Ji Joins Herbalife's Nutrition Advisory Board
Herbalife Ltd., has announced that Dr. Linong Ji has joined the company's Nutrition Advisory Board. The nutrition advisory board is comprised of leading experts around the world in the fields of nutrition and health who educate and train Herbalife independent distributors and, in China, sales employees on the principles of nutrition, physical activity and healthy lifestyle.
- OceanGrown™ International (OGI) Reveals New Weight Management Product with OceanBreakers™ - BURN
OceanGrown International is releasing a new weight management product, called OceanBreakers-BURN. BURN will feature emerging marine bioactive Fucoxanthin, a pigment from brown seaweed studied to promote fat burn.
- OceanGrown™ International (OGI) Reveals New Weight Management Product with OceanBreakers™ - BURN
OceanGrown International is releasing a new weight management product, called OceanBreakers-BURN. BURN will feature emerging marine bioactive Fucoxanthin, a pigment from brown seaweed studied to promote fat burn.
- OceanGrown™ International (OGI) Reveals New Weight Management Product with OceanBreakers™ - BURN
OceanGrown International is releasing a new weight management product, called OceanBreakers-BURN. BURN will feature emerging marine bioactive Fucoxanthin, a pigment from brown seaweed studied to promote fat burn.
- OceanGrown™ International (OGI) Reveals New Weight Management Product with OceanBreakers™ - BURN
OceanGrown International is releasing a new weight management product, called OceanBreakers-BURN. BURN will feature emerging marine bioactive Fucoxanthin, a pigment from brown seaweed studied to promote fat burn.
- OceanGrown™ International (OGI) Reveals New Weight Management Product with OceanBreakers™ - BURN
OceanGrown International is releasing a new weight management product, called OceanBreakers-BURN. BURN will feature emerging marine bioactive Fucoxanthin, a pigment from brown seaweed studied to promote fat burn.
|
Green Bay, WI (January 5, 2006) – EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand, marrying the abilities and efforts of two organizations with a track record of changing people’s lives.
The Chicken Soup for the Soul™ Supplements family is committed to the highest quality and most effective products. When Chicken Soup for the Soul® founders, Mark Victor Hansen and Jack Canfield, first began their best-selling book series their goal was to heal the heart and soul of America. Now, with Chicken Soup for the Soul™ Supplements, their goal is to heal the body and mind of America as well.
Chicken Soup for the Soul™ Supplements has just begun the launch of its complete line of all-natural nutritional supplements which they are marketing through a network of independent sales affiliates and direct response radio and TV advertising.
EuroPharma was identified by Chicken Soup for the Soul® management as having the same heart-felt commitment to enriching individuals' lives as the group at Chicken Soup for the Soul®. Through that connection, an exclusive licensing partnership was formed. Both Chicken Soup for the Soul Supplements and EuroPharma embrace similar philosophies: to make a real difference in quality of life by helping to improve the health of America one person at a time.
Terry Lemerond, who researches products on behalf of and consults to Chicken Soup for the Soul™ Supplements, was instrumental in introducing numerous “firsts” to the U.S. health market, including stabilized glucosamine sulfate, IP-6, standardization of botanical extracts and the introduction of complex supplement formulations for specific health conditions. “We are thrilled to have Terry developing our product line. He has been a leader in innovation for dietary supplements. I trust, respect and admire Terry and his team at EuroPharma." said Mark Victor Hanson, co-author of the very popular Chicken Soup for the Soul® book series and co-founder of the nutritional supplement company.
Over the past 40 years, Terry Lemerond has built an extensive network of industry scientists, innovators and experts throughout Europe and Asia, where he has partnered with several phytopharmaceutical and biotech companies to bring effective natural products to the U.S. These resources are the key to EuroPharma’s ability to source innovative new products for Chicken Soup Supplements and other partners.
EuroPharma is developing an unprecedented line of nutritional supplements exclusively for Chicken Soup for the Soul™ Supplements these formulations and unique ingredients will be innovative, proprietary and found only under the Chicken Soup for the Soul™ Supplements label.
“I am extremely proud that the team at Chicken Soup for the Soul™ Supplements, led by Mark and Jack, believe in EuroPharma’s quality and integrity and that they have selected us to form the foundation of their line of supplements. They have brought together two high quality teams to effect heath changes in America that have not yet been experienced,” said EuroPharma founder and president Terry Lemerond. “With the rise in childhood obesity, diabetes, cardiovascular disease and so many other health care concerns, now is the time to make an impact and to change the health of America.”
Chicken Soup for the Soul™ Supplements has launched an unprecedented product line of nutritional supplements that can have a lasting impact on the quality of your life. It is our goal to improve the health and enhance the lives of all who seek it though our discoveries. For more information visit www.ChickenSoupSupplements.com or call Richard W. Enlow, CEO, 636.736.2000.
Located in Green Bay, Wisconsin, EuroPharma, Inc., is committed to discovering innovative products that have been extensively researched and demonstrated to be safe, natural and effective which will help people live healthier and more fulfilling lives. EuroPharma is an extension of its founder, Terry Lemerond’s, historic successes and is a proven model of product development. For more information, visit www.EuroPharmaUSA.com.
- END -
Contact:
Suzanne Shelton 847-676-4337
Suzanne@SheltonGroupPR.com
|